On the other hand, for specific pathological states driven by RASSF4 overexpression, such as certain cancer subtypes, RNA interference technology or CRISPR-Cas9 gene editing systems are required to specifically inhibit RASSF4 expression [123]. The gene discussed is RASSF4; the disease is cancer.